Justin Penzenstadler, PharmD

Clinical Team Leader, Division of Diabetes, Lipid Disorders, and Obesity, FDA

About this speaker

Justin Penzenstadler, PharmD is a Clinical Team Leader within the Division of Diabetes, Lipid Disorders, and Obesity at FDA.

Talks

Session Three-Four Panel Discussion: C-Peptide as Biomarker in Trials of T1D

18 June 2025, 04:45 PM
Helen Colhoun Stephen Karpen Joseph Hedrick Colin Mark Dayan Kimberly Collins Peter Senior Christoph Tasto Justin Penzenstadler, PharmD